small bounce back on market. I watch S&P chart, we came close to 10,500 area which I consider dire straits. NXTM hanging tough, needs to develop handle another few days. If we can get through this rough patch NXTM may take off going into Nov.earnings report.
The problem with this stock is not the product is the debt that they carry vs revenue. They are still not profitable and with global expansion in place it may 2 to 3 years to become a profitable company and there is a cost to expansion. However if willing to wait this stock is a $45 - $50 in 2 to 3 years. However I would sit back for now and wait for the price to go back down to 17 -18 range and jump in and forget about the stock
yes, debt seems to be problem. However, each quarter it appears to be dropping. This quarter I expect to see revenues up a little more and debt down a little more. Once in a blue moon I'll check the headlines on FMS board to keep track on what's happening in that area. Found this article which maybe of interest. Accoring to the U.S. Renal Data system 400,000 americans were receiving regular dialysis at the end of 2009. Health experts expect that to double in 10 years. That's sad, but a fact of life. As you can see this part of health care is a huge market and NXTM has a chance to be a front runner with there portable diaylsis machines. Your projections of 2 to 3 years down the line could be spot on. Good hunting